ARMADA: Assessing reliable measurement in Alzheimer's disease and cognitive aging project methods.

Aged Aged, 80 and over Aging Alzheimer Disease Cognitive Aging Cognitive Dysfunction / psychology Humans Longitudinal Studies Neuropsychological Tests
Alzheimer's disease NIH Toolbox cognition dementia mild cognitive impairment neuropsychology

Journal

Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978

Informations de publication

Date de publication:
08 2022
Historique:
revised: 26 07 2021
received: 07 01 2021
accepted: 07 09 2021
pubmed: 18 11 2021
medline: 23 8 2022
entrez: 17 11 2021
Statut: ppublish

Résumé

Early detection of cognitive decline in older adults is a public health priority. Advancing Reliable Measurement in Alzheimer's Disease and Cognitive Aging (ARMADA), a multisite study, is validating cognition, emotion, motor, and sensory modules of the National Institutes of Health Toolbox for Assessment of Neurological and Behavioral Function (NIHTB) in the aging spectrum from cognitively normal to dementia of the Alzheimer's type (DAT). Participants 65 to 85 years old, in demographic groups racially proportional to the general US population, are recruited in one of three groups to validate the NIHTB: cognitively normal, amnestic mild cognitive impairment (aMCI), or mild DAT. Additional special emphasis cohorts include (1) Blacks in the three clinical groups; (2) Spanish-speakers in the three clinical groups; (3) cognitively normal, population-proportional, over age 85. Longitudinal study will determine whether NIHTB can predict cognitive decline and is associated with Alzheimer's disease biomarkers. Here, we detail the methods for the ARMADA study.

Identifiants

DOI: 10.1002/alz.12497 PMID: 34786833 PMC: PMC9110564
pubmed: 34786833
doi: 10.1002/alz.12497
pmc: PMC9110564
mid: NIHMS1743026
doi:

Types de publication

Journal Article Multicenter Study Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1449-1460

Subventions

Organisme : NIA NIH HHS
ID : U19 AG073153
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG058724
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG016976
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062429
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG054023
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG005133
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG037212
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG045571
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001873
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG025204
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG033514
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG013854
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG053760
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG045571
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG047866
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066518
Pays : United States
Organisme : NIA NIH HHS
ID : P50 AG016574
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066511
Pays : United States
Organisme : NIA NIH HHS
ID : U24 AG072122
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG054484
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062421
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG036694
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG067781
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG007232
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG072977
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG052446
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG062715
Pays : United States
Organisme : NIA NIH HHS
ID : U2C AG057441
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG066468
Pays : United States

Informations de copyright

© 2021 the Alzheimer's Association.

Références

J Int Neuropsychol Soc. 2019 Sep;25(8):857-867
pubmed: 31256769
Neurology. 2015 Jan 13;84(2):182-9
pubmed: 25471394
J Intern Med. 2004 Sep;256(3):183-94
pubmed: 15324362
Neurol Clin Pract. 2017 Feb;7(1):5-14
pubmed: 28243501
Lancet Neurol. 2013 Apr;12(4):357-67
pubmed: 23477989
Arch Gerontol Geriatr. 2009 Jul-Aug;49(1):146-9
pubmed: 18692255
Neuropsychologia. 2011 Jan;49(1):43-8
pubmed: 21029744
JAMA Neurol. 2016 Jan;73(1):93-101
pubmed: 26569387
J Int Neuropsychol Soc. 2013 Mar;19(3):272-83
pubmed: 23298442
J Gerontol. 1982 May;37(3):323-9
pubmed: 7069156
Arch Neurol. 2010 Aug;67(8):980-6
pubmed: 20697049
Alzheimers Dement. 2011 May;7(3):270-9
pubmed: 21514249
Alzheimers Dement (N Y). 2020 Nov 24;6(1):e12103
pubmed: 33283037
J Alzheimers Dis. 2015;50(1):71-6
pubmed: 26639973
JAMA Neurol. 2014 Aug;71(8):961-70
pubmed: 24886908
Int J Geriatr Psychiatry. 2000 Nov;15(11):1021-7
pubmed: 11113982
Neurobiol Aging. 2008 May;29(5):693-706
pubmed: 17207898
Alzheimers Res Ther. 2017 Nov 2;9(1):88
pubmed: 29096697
Neurology. 2013 Mar 12;80(11 Suppl 3):S32-6
pubmed: 23479541
Neuropsychologia. 2011 Jul;49(9):2776-83
pubmed: 21689670
Neurology. 2013 Mar 12;80(11 Suppl 3):S2-6
pubmed: 23479538
Neurology. 2013 Mar 12;80(11 Suppl 3):S54-64
pubmed: 23479546
Arch Neurol. 2009 Nov;66(11):1339-44
pubmed: 19901164
Neurology. 2013 Mar 12;80(11 Suppl 3):S45-8
pubmed: 23479544
Neurology. 2013 Mar 12;80(11 Suppl 3):S76-86
pubmed: 23479549
Neurology. 1998 May;50(5):1496-8
pubmed: 9596020
J Alzheimers Dis. 2012;31(2):265-75
pubmed: 22543846
Arch Clin Neuropsychol. 2014 Nov;29(7):663-9
pubmed: 25280795
Mol Psychiatry. 2012 Nov;17(11):1056-76
pubmed: 22143004
Int Psychogeriatr. 2013 Jul;25(7):1157-66
pubmed: 23597130
J Prev Alzheimers Dis. 2017;4(1):3-11
pubmed: 29188853
Neurobiol Aging. 1996 Jan-Feb;17(1):123-30
pubmed: 8786794
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
Expert Rev Neurother. 2011 May;11(5):665-76
pubmed: 21539487
J Am Geriatr Soc. 2005 Apr;53(4):695-9
pubmed: 15817019
Neurology. 2013 Mar 12;80(11 Suppl 3):S25-31
pubmed: 23479540
Alzheimer Dis Assoc Disord. 2018 Jan-Mar;32(1):10-17
pubmed: 29240561
Alzheimer Dis Assoc Disord. 2009 Apr-Jun;23(2):91-101
pubmed: 19474567
Neurology. 2012 Jun 12;78(24):1946-52
pubmed: 22689734
Alzheimers Dement (Amst). 2018 Nov 02;10:764-772
pubmed: 30505926
Alzheimer Dis Assoc Disord. 2006 Oct-Dec;20(4):210-6
pubmed: 17132964
Alzheimers Dement. 2011 Jan;7(1):110-23
pubmed: 21255748
Alzheimers Dement. 2019 Feb;15(2):292-312
pubmed: 30555031
Arch Clin Neuropsychol. 2017 Aug 01;32(5):555-573
pubmed: 28334392
Lancet Neurol. 2010 Feb;9(2):138-9
pubmed: 20129161
Neurology. 2013 Mar 12;80(11 Suppl 3):S49-53
pubmed: 23479545
Arch Neurol. 2001 Dec;58(12):1985-92
pubmed: 11735772
Neurology. 2001 Jan 9;56(1):49-56
pubmed: 11148235
Neurology. 2013 Mar 12;80(11 Suppl 3):S37-40
pubmed: 23479542
Arch Neurol. 2006 Dec;63(12):1763-9
pubmed: 17172617
Neurobiol Aging. 2016 Aug;44:1-8
pubmed: 27318129
Cold Spring Harb Perspect Med. 2012 Aug 01;2(8):
pubmed: 22908189
JAMA. 2014 Dec 17;312(23):2551-61
pubmed: 25514304
Clin Neuropsychol. 2010 Apr;24(3):429-53
pubmed: 20373222
Neurology. 2013 Mar 12;80(11 Suppl 3):S20-4
pubmed: 23479539
Arch Phys Med Rehabil. 2000 Dec;81(12 Suppl 2):S15-20
pubmed: 11128900
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Clin Neuropsychol. 2021 Feb;35(2):236-252
pubmed: 32141802
Hum Mol Genet. 1994 Apr;3(4):569-74
pubmed: 8069300
JAMA. 2020 Feb 25;323(8):757-763
pubmed: 32096858
Neurology. 2013 Mar 12;80(11 Suppl 3):S65-75
pubmed: 23479547
Front Aging Neurosci. 2016 Dec 08;8:298
pubmed: 28008314
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248
Neurology. 2000 Jan 11;54(1):240-2
pubmed: 10636159
Neurology. 2013 Mar 12;80(11 Suppl 3):S41-4
pubmed: 23479543
J Am Geriatr Soc. 2018 May;66(5):969-975
pubmed: 29608782
Clin Neuropsychol. 2005 Jun;19(2):270-5
pubmed: 16019708
Ann Neurol. 2004 Mar;55(3):306-19
pubmed: 14991808

Auteurs

Sandra Weintraub (S)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Tatiana Karpouzian-Rogers (T)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

John Devin Peipert (JD)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Cindy Nowinski (C)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Jerry Slotkin (J)

Center for Health Assessment Research and Translation, University of Delaware, Newark, Delaware, USA.

Katy Wortman (K)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Emily Ho (E)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Emily Rogalski (E)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Department of Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Cynthia Carlsson (C)

Department of Medicine, University of Wisconsin-Madison School of Medicine and Public Health and Wisconsin Alzheimer's Disease Research Center, Madison, Wisconsin, USA.

Bruno Giordani (B)

Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.

Felicia Goldstein (F)

Department of Neurology, Emory University, Atlanta, Georgia, USA.

John Lucas (J)

Department of Psychiatry and Psychology, Mayo Clinic, Jacksonville, Florida, USA.

Jennifer J Manly (JJ)

Department of Neurology, Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University, Columbia University, New York, New York, USA.

Dorene Rentz (D)

Department of Neurology, Massachusetts General Hospital and Brigham and Women's Hospital, Harvard Medical School, Boston, USA.

David Salmon (D)

Department of Neurosciences, University of California San Diego, La Jolla, California, USA.

Beth Snitz (B)

Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.

Hiroko H Dodge (HH)

Department of Neurology, Layton Aging and Alzheimer's Disease Center, Oregon Health & Science University, Portland, Oregon, USA.

Michaela Riley (M)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Fatima Eldes (F)

Mesulam Center for Cognitive Neurology and Alzheimer's Disease, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Vitali Ustsinovich (V)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Richard Gershon (R)

Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › ARMADA: Assessing reliable measurement in...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Sujet âgé de 80 ans ou plus › ARMADA: Assessing reliable measurement in...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Vieillissement › ARMADA: Assessing reliable measurement in...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Démence › Maladie d'Alzheimer › ARMADA: Assessing reliable measurement in...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Vieillissement › Vieillissement cognitif › ARMADA: Assessing reliable measurement in...
questionsmedicales.fr › Troubles mentaux › Troubles neurocognitifs › Troubles de la cognition › Dysfonctionnement cognitif › ARMADA: Assessing reliable measurement in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › ARMADA: Assessing reliable measurement in...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études longitudinales › ARMADA: Assessing reliable measurement in...
questionsmedicales.fr › Disciplines et activités comportementales › Tests psychologiques › Tests neuropsychologiques › ARMADA: Assessing reliable measurement in...